N6-dipeptide derivatives of N12-ribosyl-indolo[2,3-a]carbazole |
| |
Authors: | O. V. Goryunova G. M. Zakharchuk O. S. Zhukova L. V. Fetisova N. E. Kuzmina |
| |
Affiliation: | 1. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Kashirskoe sh. 24, Moscow, 115478, Russia 2. Scientific Center for Medical Application Products, Ministry of Health of the Russian Federation, Moscow, 127051, Russia
|
| |
Abstract: | N6-derivatives of N12-indolo[2,3-a]pirrolo[3,4-c]carbazole-5,7-dione are synthesized as potential antitumor agents. The pyrrol N6 atom of these compounds is included into the dipeptide residue of the general formula >N6-(CH2) n -CO-Ala/βAla-OMe (n = 2 or 3). These compounds are synthesized by the reaction in DMF at 130°C between 13-methyl-12-(2,3,4-tri-O-acetyl-β-D-ribopyranosyl)indolo[2,3-a]furano[3,4-c]carbazole-5,7-dione and dipeptides containing the free N-terminal amino group. The nitrogen atom of the peptide amino group replaces O6 in the furan ring and is embedded as the N6 imide nitrogen atom of pyrrol. The ability of the compounds obtained to inhibit the growth of the SKOV3 human ovarian carcinoma cells was studied. The only derivative containing the >N6-(CH2)3-CO-L-Ala-OMe radical showed the cytotoxic activity with an inhibitory concentration of IC50 = 8 μM. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|